UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$288M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$215M |
| 3 |
Tractor Supply
TSCO
|
+$157M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
PayPal
PYPL
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$339M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$244M |
| 3 |
PX
Praxair Inc
PX
|
+$218M |
| 4 |
Meta Platforms (Facebook)
META
|
+$182M |
| 5 |
Adobe
ADBE
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 14.9% |
| 3 | Financials | 14.08% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRHC
826
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $10.6M | 0.01% |
166,024
-42,918
| -21% | -$3.04M |
|
827
Kennametal
KMT
$2.58B
| $10.6M | 0.01% |
317,807
-11,797
| -4% | -$448K |
|
828
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $10.4M | 0.01% |
281,654
+189,133
| +204% | +$7.49M |
|
|
IMMU
829
DELISTED
Immunomedics Inc
IMMU
| $10.4M | 0.01% |
726,958
+65,717
| +10% | +$1.3M |
|
|
CLR
830
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $10.4M | 0.01% |
257,539
-7,152
| -3% | -$366K |
|
831
Bankunited
BKU
$3.37B
| $10.3M | 0.01% |
345,052
-24,952
| -7% | -$813K |
|
832
Essent Group
ESNT
$6.04B
| $10.3M | 0.01% |
301,064
-20,934
| -7% | -$801K |
|
|
VISN
833
Vistance Networks Inc
VISN
$2.28B
| $10.3M | 0.01% |
627,426
+36,204
| +6% | +$768K |
|
834
iShares Russell 1000 Value ETF
IWD
$83.2B
| $10.3M | 0.01% |
92,495
-17,763
| -16% | -$2.13M |
|
835
Huazhu Hotels Group
HTHT
$13.2B
| $10.3M | 0.01% |
358,670
+51,912
| +17% | +$1.5M |
|
836
West Pharmaceutical
WST
$24.5B
| $10.2M | 0.01% |
104,440
+11,687
| +13% | +$1.27M |
|
837
National Bank Holdings
NBHC
$1.91B
| $10.2M | 0.01% |
328,850
-24,050
| -7% | -$833K |
|
838
Charles River Laboratories
CRL
$12.8B
| $10.1M | 0.01% |
89,591
-2,055
| -2% | -$257K |
|
839
Banco Santander Chile
BSAC
$16.8B
| $10.1M | 0.01% |
339,073
| – | – |
|
|
ISBC
840
DELISTED
Investors Bancorp, Inc.
ISBC
| $10.1M | 0.01% |
973,986
-81,003
| -8% | -$935K |
|
841
Coty
COTY
$2.39B
| $10M | 0.01% |
1,530,836
+45,195
| +3% | +$417K |
|
842
Under Armour
UAA
$2.73B
| $10M | 0.01% |
565,849
+24,693
| +5% | +$507K |
|
843
Ligand Pharmaceuticals
LGND
$6.02B
| $9.99M | 0.01% |
117,957
-7,156
| -6% | -$763K |
|
844
Upland Software
UPLD
$12.6M
| $9.96M | 0.01% |
36,647
-2,836
| -7% | -$851K |
|
|
PGRE
845
DELISTED
Paramount Group
PGRE
| $9.93M | 0.01% |
790,974
+99,785
| +14% | +$1.4M |
|
846
Shake Shack
SHAK
$2.83B
| $9.9M | 0.01% |
217,955
-7,213
| -3% | -$372K |
|
|
AAN.A
847
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $9.89M | 0.01% |
235,161
-46,952
| -17% | -$1.97M |
|
|
SINA
848
DELISTED
Sina Corp
SINA
| $9.84M | 0.01% |
183,353
+33,249
| +22% | +$2.05M |
|
849
Nordson
NDSN
$17.2B
| $9.79M | 0.01% |
82,051
-734
| -0.9% | -$90.1K |
|
850
SAP
SAP
$230B
| $9.78M | 0.01% |
98,272
-4,063
| -4% | -$432K |
|
Similar funds
UBS AM's Q4 2018 Portfolio in Review
As of Q4 2018, UBS AM held 2,899 positions worth $116B, down 14% from $135B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS AM's Q4 2018 filing shows 140 new, 1,359 increased, 845 reduced and 130 closed positions. Its largest new stake was Linde: 1,823,057 shares worth $284M. The largest sale was Aetna Inc, an estimated $339M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2018 buy was Linde: 1,823,057 shares worth $284M.
- UBS AM added most to iShares US Treasury Bond ETF in Q4 2018, an estimated $215M increase.
- UBS AM's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $182M.
- UBS AM fully exited Aetna Inc in Q4 2018, selling an estimated $339M.
- UBS AM's ten largest holdings make up 17% of its $116B portfolio in Q4 2018.
- UBS AM opened 140 new positions and closed 130 in Q4 2018.
- UBS AM's portfolio value fell 14% quarter-over-quarter to $116B.
Based on UBS AM's 13F filing for Q4 2018, filed 13 Feb 2019.